Skip to main content
Podcast

Vikas Majithia, MD, on New and Existing Treatments for AxSpA

Dr Majithia discusses the options for treating axial spondyloarthritis, including the newest approved agent, upadacitinib.

Vikas Majithia, MD, is chair of the Division of Rheumatology and a senior associate consultant in the Department of Medicine at Mayo Clinic-Florida in Jacksonville.